Radiotherapy acts as an in situ vaccine, inducing immunogenic cell death and activating the cGAS-STING pathway to stimulate type I interferon (IFN-α/β) production, which enhances dendritic cell maturation and tumor antigen presentation (6). The gene discussed is STING1; the disease is neoplasm.